The US Food and Drug Administration (FDA) has awarded an Emergency Use Authorization (EUA) for a Covid-19 antigen diagnostic test, the BD Veritor System for Rapid Detection of SARS-CoV-2 virus. This approval marks the second antigen test for SARS-CoV-2 antigen detection to have received EUA from FDA.
Julius Group has partnered with Noble Biomaterials for the production of reusable antiviral/antibacterial gloves and masks. This partnership will enable Julius Group to produce PPE using Ionic+ antimicrobial technology of Noble Biomaterials. The reusable antimicrobial gloves and masks will be produced from fabric that has 99.9% pure silver which is expected to reduce the virus infectivity on soft surfaces.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Chembio Diagnostics plans to submit applications for EUA to the FDA for a revised version of the DPP COVID-19 IgM/IgG System and DPP COVID-19 Antigen System. The DPP COVID-19 IgM/IgG System is a Covid-19 point-of-care serology system while the DPP COVID-19 Antigen System is a new Covid-19 point-of-care antigen system.
Centogene has partnered with OESIS Network to carry out Covid-19 screening of schools in the US. With this partnership, RT-PCR testing will support schools to restart classes on campus in the fall and for continued screening to avoid a resurgence of Covid-19 outbreak.
